© JANSSEN BIOTECH, INC. 2024

About Us

My Prostate Cancer Roadmap is intended to support you, whether you have advanced prostate cancer or care for someone who does. The site explores the complexities of diagnosing, treating, and living with advanced prostate cancer. Use the resources here to create a unique roadmap for your journey and be sure to stop back often to get the latest insights from oncologists, urologists, nurses, social workers, and other experts who have helped many others with the journey that you’re on now.

My Prostate Cancer Roadmap is brought to you by Janssen Biotech, Inc., in collaboration with the Prostate Conditions Education Council (PCEC), the Prostate Cancer Research Institute (PCRI), the Prostate Health Education Network (PHEN), Us TOO International Prostate Cancer Education & Support Network (Us TOO), and ZERO - The End of Prostate Cancer (ZERO). The views and opinions shared by medical and other experts on the website are those of the experts and are not necessarily representative of the views and opinions of either Janssen Biotech, Inc., PCEC, PCRI, PHEN, Us TOO, or ZERO. Some experts were reimbursed for their time taken to share information and to write and review content for the website. Participants were reimbursed for travel expenses related to the program. Janssen Biotech, Inc., provides sponsorship funding to PCEC, PCRI, PHEN, Us TOO, and ZERO in support of the My Prostate Cancer Roadmap program and other education and support initiatives benefiting prostate cancer patients and their families.

Janssen Biotech, Inc.

janssenbiotech.com
1-800-JANSSEN (1-800-526-7736) 
Follow us on X at x.com/JanssenUS

Disclaimer

You are now leaving MyProstateCancerRoadmap.com. By clicking "Continue" below, you will be taken to an external site that may contain links or references to other websites to which our Privacy Policy may not apply. We encourage you to read the Privacy Policy of every website you visit. Our Privacy Policy can be reviewed by clicking here. You are solely responsible for your interactions with such websites.

Continue